Caxton Associates LP Eli Lilly & CO Transaction History

Caxton Associates LP

$2.65 Billion
Q3 2024

A detailed history of Caxton Associates LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Caxton Associates LP holds 3,670 shares of LLY stock, worth $2.74 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

3,670

Previous 5,131 28.47%

Holding current value

$2.74 Million

Previous $4.65 Million 30.01%

% of portfolio

0.12%

Previous 0.16%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $1.13 Million - $1.4 Million	-1,461 Reduced 28.47%	3,670 $3.25 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $310,244 - $389,069	428 Added 9.1%	5,131 $4.65 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $2.79 Million - $3.73 Million	4,703 New	4,703 $3.66 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $67.8 Million - $79.1 Million	211,000 New	211,000 $77.2 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $737,630 - $916,687	-3,143 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $406,978 - $505,062	-1,810 Reduced 36.54%	3,143 $868,000
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $1.1 Million - $1.35 Million	4,953 New	4,953 $1.14 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $503,053 - $665,661	-3,856 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $227,518 - $263,166	1,556 Added 67.65%	3,856 $571,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $13,641 - $16,418	-100 Reduced 4.17%	2,300 $378,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $285,720 - $353,640	2,400 New	2,400 $333,000
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $618,639 - $766,239	-5,786 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $223,831 - $243,471	2,096 Added 56.8%	5,786 $647,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $408,815 - $477,190	3,690 New	3,690 $409,000
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $247,064 - $276,787	-2,333 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $200,311 - $250,354	2,333 New	2,333 $250,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $1.2 Million - $1.42 Million	-16,228 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $1.33 Million - $1.43 Million	16,228	16,228 $1.37 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Account

Caxton Associates LP Eli Lilly & CO Transaction History